Hemotek, LLC — Department of Defense SBIR Phase I: J201-CSO1
Hemotek, LLC — SBIR Phase I award from Department of Defense.
- Amount
- $49,920
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- J201-CSO1
- Solicitation
- 20.1
- NAICS
- —
- Place of performance
- TX
- Period
- 2020-03-09 → 2020-06-09
Description
Ox66™ is oxygen in a non-toxic solid powdered form. It can be easily applied in multiple forms, as a powder, a spray, tonic, and as a salve to accelerate healing. Ox66™ targets hypoxic conditions and provides lost oxygen back to the wound, reducing the incidence of infection, triggering natural healing responses, and relieving pain.